StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ONCO

Onconetix, Inc.

ONCO Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.81
+0.03 +3.19%

Key statistics

from XBRL data in SEC filings
Market cap
$9.30M
Revenue (TTM)
$735K
Net income (TTM)
-$9.70M
EPS (TTM)
$203.98
P/E ratio
0.0
Dividend yield
151.65%
Free cash flow
-$9.71M
Cash
$3.72M
Total assets
$14.8M
Gross margin
79.6%
52-week range
$0.67 – $209.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Unregistered sale of equity Jul 29, 2026 8-K Amended charter or bylaws; Other events May 19, 2026 8-K Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Shareholder vote results May 4, 2026 8-K Director or officer change Apr 24, 2026 8-K Amended charter or bylaws; Other events Mar 27, 2026 8-K/A Director or officer change Mar 25, 2026 8-K Director or officer change Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Entered a material agreement; Other events Feb 12, 2026 8-K Shareholder vote results Feb 9, 2026 8-K Director or officer change; Shareholder vote results Dec 10, 2025 8-K Entered a material agreement Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Item 5.08 Oct 29, 2025 8-K Entered a material agreement; Unregistered sale of equity Oct 3, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 26, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 22, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Director or officer change Aug 12, 2025 8-K Entered a material agreement; Director or officer change; Other events Jul 16, 2025 8-K Regulation FD disclosure Jun 16, 2025 10-Q Quarter ended 2025-03-31 Jun 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jun 11, 2025 8-K Shareholder vote results Jun 5, 2025 10-K Fiscal year ended 2024-12-31 Jun 2, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Delisting notice or listing-rule failure May 22, 2025 8-K Delisting notice or listing-rule failure Apr 30, 2025 8-K Delisting notice or listing-rule failure; Other events Apr 18, 2025 8-K Other events Apr 8, 2025 8-K Director or officer change Apr 3, 2025 8-K Regulation FD disclosure Mar 24, 2025 8-K Regulation FD disclosure Mar 19, 2025 8-K Entered a material agreement; Director or officer change; Item 5.08 Feb 28, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Changed accountants; Director or officer change Feb 18, 2025 8-K Delisting notice or listing-rule failure Jan 24, 2025 8-K Other events Jan 22, 2025 8-K Delisting notice or listing-rule failure; Other events Dec 12, 2024